FY2025 EPS Estimates for Tilray Lifted by Atb Cap Markets

Tilray Inc (NASDAQ:TLRY) – Research analysts at Atb Cap Markets upped their FY2025 earnings per share estimates for Tilray in a note issued to investors on Monday, December 16th. Atb Cap Markets analyst F. Gomes now forecasts that the company will post earnings of ($0.13) per share for the year, up from their previous estimate of ($0.14). The consensus estimate for Tilray’s current full-year earnings is ($0.14) per share. Atb Cap Markets also issued estimates for Tilray’s FY2026 earnings at ($0.11) EPS, FY2027 earnings at ($0.04) EPS and FY2029 earnings at $0.05 EPS.

Separately, Roth Mkm dropped their price target on Tilray from $2.00 to $1.75 and set a “neutral” rating on the stock in a research report on Friday, October 11th.

Tilray Trading Up 4.3 %

Shares of NASDAQ TLRY traded up $0.05 during trading hours on Thursday, hitting $1.21. The company’s stock had a trading volume of 5,708,618 shares, compared to its average volume of 25,748,680. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.57 and a current ratio of 2.47. The stock has a market cap of $1.09 billion, a price-to-earnings ratio of -4.48 and a beta of 2.08. The business has a 50-day simple moving average of $1.45 and a 200-day simple moving average of $1.66. Tilray has a 12 month low of $1.15 and a 12 month high of $2.97.

Tilray (NASDAQ:TLRY) last released its quarterly earnings results on Thursday, October 10th. The company reported ($0.04) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.04). The business had revenue of $200.00 million for the quarter, compared to the consensus estimate of $218.70 million. Tilray had a negative return on equity of 2.00% and a negative net margin of 26.79%. The company’s revenue for the quarter was up 13.0% on a year-over-year basis. During the same quarter last year, the business posted ($0.10) earnings per share.

Insider Buying and Selling at Tilray

In related news, CFO Carl A. Merton acquired 26,000 shares of the business’s stock in a transaction that occurred on Friday, November 15th. The stock was bought at an average cost of $1.36 per share, for a total transaction of $35,360.00. Following the purchase, the chief financial officer now owns 26,000 shares in the company, valued at $35,360. The trade was a ∞ increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 0.87% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Tilray

A number of hedge funds have recently made changes to their positions in TLRY. BNP Paribas Financial Markets grew its position in shares of Tilray by 1,314.1% during the third quarter. BNP Paribas Financial Markets now owns 1,819,494 shares of the company’s stock valued at $3,202,000 after purchasing an additional 1,690,827 shares in the last quarter. Point72 Asset Management L.P. bought a new position in shares of Tilray during the 3rd quarter valued at approximately $1,348,000. Bank of Montreal Can grew its holdings in shares of Tilray by 19.6% in the second quarter. Bank of Montreal Can now owns 2,169,100 shares of the company’s stock valued at $3,622,000 after purchasing an additional 355,778 shares in the last quarter. XTX Topco Ltd increased its position in Tilray by 1,079.7% in the third quarter. XTX Topco Ltd now owns 281,504 shares of the company’s stock worth $495,000 after purchasing an additional 257,641 shares during the last quarter. Finally, Barclays PLC lifted its position in Tilray by 600.4% during the third quarter. Barclays PLC now owns 204,144 shares of the company’s stock valued at $359,000 after purchasing an additional 174,997 shares during the last quarter. Institutional investors own 9.35% of the company’s stock.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.